Literature DB >> 27158394

Tumor-suppressive miR-99a inhibits cell proliferation via targeting of TNFAIP8 in osteosarcoma cells.

Beiguang Xing1, Cong Ren2.   

Abstract

Osteosarcoma (OS) has been described as the most common primary malignant bone tumor in adolescents and young adults worldwide. MicroRNAs (miRNAs) have demonstrated playing critical role on the cellular biology and development of cancer. However, the essential mechanisms of miRNAs underlying osteosarcoma oncogenesis and progression have not fully understood. In this study, we found that the expression of miR-99a was repressed in OS tissues and cells using qRT-PCR assays. We demonstrated that overexpression of miR-99a inhibits OS cell viability and growth with MTT, colony formation and in vivo mice experiment. In addition, FACS and Annexin V assays identified that miR-99a can induce OS cell cycle progression and cell apoptosis. Furthermore, we demonstrated that TNFAIP8 is a direct target of miR-99a and is upregulated in OS samples and cells. Knockdown of TNFAIP8 significantly attenuated OS cell viability and growth through inhibiting cell cycle and inducing cell apoptosis in vitro and in vivo. These findings establish that miR-99a plays a significant tumor-suppressing role in OS and proposes it as a potential diagnostic and therapeutic target in managing OS metastases.

Entities:  

Keywords:  MG-63; TNFAIP8; U2OS; miR-99a; osteosarcoma

Year:  2016        PMID: 27158394      PMCID: PMC4846951     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  24 in total

1.  Identification of seven differentially displayed transcripts in human primary and matched metastatic head and neck squamous cell carcinoma cell lines: implications in metastasis and/or radiation response.

Authors:  S Patel; F H Wang; T L Whiteside; U Kasid
Journal:  Oral Oncol       Date:  1997-05       Impact factor: 5.337

2.  Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma.

Authors:  Zujian Chen; Yi Jin; Dongsheng Yu; Anxun Wang; Ishrat Mahjabeen; Cheng Wang; Xiqiang Liu; Xiaofeng Zhou
Journal:  Oral Oncol       Date:  2012-03-17       Impact factor: 5.337

3.  Identification of a novel tumor necrosis factor-alpha-inducible gene, SCC-S2, containing the consensus sequence of a death effector domain of fas-associated death domain-like interleukin- 1beta-converting enzyme-inhibitory protein.

Authors:  D Kumar; T L Whiteside; U Kasid
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

4.  miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222.

Authors:  M Acunzo; R Visone; G Romano; A Veronese; F Lovat; D Palmieri; A Bottoni; M Garofalo; P Gasparini; G Condorelli; M Chiariello; C M Croce
Journal:  Oncogene       Date:  2011-06-27       Impact factor: 9.867

5.  Functional variants in TNFAIP8 associated with cervical cancer susceptibility and clinical outcomes.

Authors:  Ting-Yan Shi; Xi Cheng; Ke-Da Yu; Meng-Hong Sun; Zhi-Ming Shao; Meng-Yun Wang; Mei-Ling Zhu; Jing He; Qiao-Xin Li; Xiao-Jun Chen; Xiao-Yan Zhou; Xiaohua Wu; Qingyi Wei
Journal:  Carcinogenesis       Date:  2013-01-08       Impact factor: 4.944

6.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Calin Dan Dumitru; Masayoshi Shimizu; Roberta Bichi; Simona Zupo; Evan Noch; Hansjuerg Aldler; Sashi Rattan; Michael Keating; Kanti Rai; Laura Rassenti; Thomas Kipps; Massimo Negrini; Florencia Bullrich; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-14       Impact factor: 11.205

7.  Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression.

Authors:  Chuanbo Zhang; Debyani Chakravarty; Isamu Sakabe; Rajshree R Mewani; Howard E Boudreau; Deepak Kumar; Imran Ahmad; Usha N Kasid
Journal:  Mol Ther       Date:  2006-02-07       Impact factor: 11.454

8.  The significance of TNFAIP8 in prostate cancer response to radiation and docetaxel and disease recurrence.

Authors:  Chuanbo Zhang; Bhaskar V Kallakury; Jeffrey S Ross; Rajshree R Mewani; Christine E Sheehan; Isamu Sakabe; George Luta; Deepak Kumar; Sivaramakrishna Yadavalli; Joshua Starr; Taduru L Sreenath; Shiv Srivastava; Harvey B Pollard; Ofer Eidelman; Meera Srivastava; Usha N Kasid
Journal:  Int J Cancer       Date:  2013-01-10       Impact factor: 7.396

Review 9.  MicroRNAome genome: a treasure for cancer diagnosis and therapy.

Authors:  Ioana Berindan-Neagoe; Paloma del C Monroig; Barbara Pasculli; George A Calin
Journal:  CA Cancer J Clin       Date:  2014-08-07       Impact factor: 508.702

10.  Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix.

Authors:  Long Huang; Jia-Xin Lin; Yan-Hong Yu; Mei-Yin Zhang; Hui-Yun Wang; Min Zheng
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

View more
  17 in total

1.  SCC-S2 Facilitates Tumor Proliferation and Invasion via Activating Wnt Signaling and Depressing Hippo Signaling in Colorectal Cancer Cells and Predicts Poor Prognosis of Patients.

Authors:  Chuanjia Yang; Weixue Xu; Xiangzhen Meng; Siqi Zhou; Minglu Zhang; Dongxu Cui
Journal:  J Histochem Cytochem       Date:  2018-09-14       Impact factor: 2.479

Review 2.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

3.  MicroRNA-9 inhibits the gastric cancer cell proliferation by targeting TNFAIP8.

Authors:  Hong-Yu Gao; Fu-Chun Huo; Hai-Yan Wang; Dong-Sheng Pei
Journal:  Cell Prolif       Date:  2017-01-27       Impact factor: 6.831

4.  MiRNA-99a can regulate proliferation and apoptosis of human granulosa cells via targeting IGF-1R in polycystic ovary syndrome.

Authors:  Yudi Geng; Cong Sui; Yang Xun; Qiaohong Lai; Lei Jin
Journal:  J Assist Reprod Genet       Date:  2018-10-29       Impact factor: 3.412

5.  Upregulation of miR-99a is associated with poor prognosis of acute myeloid leukemia and promotes myeloid leukemia cell expansion.

Authors:  Xiaohui Si; Xiaoyun Zhang; Xing Hao; Yunan Li; Zizhen Chen; Yahui Ding; Hui Shi; Jie Bai; Yingdai Gao; Tao Cheng; Feng-Chun Yang; Yuan Zhou
Journal:  Oncotarget       Date:  2016-11-22

6.  TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway.

Authors:  Ying Xing; Yuechao Liu; Tianbo Liu; Qingwei Meng; Hailing Lu; Wei Liu; Jing Hu; Chunhong Li; Mengru Cao; Shi Yan; Jian Huang; Ting Wang; Li Cai
Journal:  Cell Commun Signal       Date:  2018-07-31       Impact factor: 5.712

Review 7.  Tumor Necrosis Factor-α Induced Protein 8: Pathophysiology, Clinical Significance, and Regulatory Mechanism.

Authors:  Lei Zhang; Ran Liu; Ying-Yi Luan; Yong-Ming Yao
Journal:  Int J Biol Sci       Date:  2018-03-10       Impact factor: 6.580

8.  microRNA-544 promoted human osteosarcoma cell proliferation by downregulating AXIN2 expression.

Authors:  Ming Chen; Yong-Yi Liu; Min-Qing Zheng; Xin-Liang Wang; Xing-Hua Gao; Lin Chen; Guang-Ming Zhang
Journal:  Oncol Lett       Date:  2018-03-08       Impact factor: 2.967

9.  Biological role and clinical value of miR-99a-5p in head and neck squamous cell carcinoma (HNSCC): A bioinformatics-based study.

Authors:  Yu-Ting Chen; Jian-Ni Yao; Yu-Tao Qin; Kai Hu; Fang Wu; Ye-Ying Fang
Journal:  FEBS Open Bio       Date:  2018-06-26       Impact factor: 2.693

10.  Expression of microRNA-99a-3p in Prostate Cancer Based on Bioinformatics Data and Meta-Analysis of a Literature Review of 965 Cases.

Authors:  Hai-Biao Yan; Yu Zhang; Jie-Mei Cen; Xiao Wang; Bin-Liang Gan; Jia-Cheng Huang; Jia-Yi Li; Qian-Hui Song; Sheng-Hua Li; Gang Chen
Journal:  Med Sci Monit       Date:  2018-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.